Genfit

GNFT

GNFT Genfit NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    GNFT Chart
    See on advanced chart >

    About

    Genfit S.A. is a late-stage clinical biopharmaceutical company dedicated to the discovery and development of innovative drug candidates and diagnostic solutions targeting metabolic and liver-related diseases where there is considerable unmet medical need....
    • Highlight
      A late-stage biopharmaceutical company that develops therapeutic diagnostic solutions for metabolic liver-related diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      03/27/2019
    • Established Date
      Invalid Date
    • Full-time Employees
      159
    • Address
      Parc Eurasante 885 avenue Eugene Avinee 59120 Loos France
    • Tel
      33-3-20164000
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      American Depositary Receipt (Common Stock)